On 7 December, Ryman Healthcare launched a NZ$100-150 million (US$70.4-105.6 million), six-year, senior-secured transaction. Indicative price guidance for the deal, which is expected to price on 10 December, is 200-220 basis points area over mid-swap. ANZ, Forsyth Barr, Hobson Wealth and Westpac Banking Corporation New Zealand Branch are leading.
